Current knowledge on the genetic factors involved in moyamoya disease

Brain and Nerve

Volumn 60, Issue 11, 2008, Pages 1261-1269

  Hashikata, Hirokuni ^a   Liu, Wanyang ^a   Mineharu, Yohei ^a   Inoue, Kayoko ^a   Takenaka, Katsunobu ^b   Ikeda, Hidetoshi ^c   Houkin, Kiyohiro ^d   Kuroda, Satoshi ^e   Kikuchi, Kenji ^f   Kimura, Mitsuru ^g   Taki, Takuyuu ^h   Sonobe, Makoto ⁱ   Ban, Sadahiko ^j   Nogaki, Hidekazu ^k   Handa, Akira ^l   Kikuta, Kenichiro ^a   Takagi, Yasushi ^a   Nozaki, Kazuhiko ^m   Hashimoto, Nobuo ⁿ   Koizumi, Akio ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Takayama Red Cross Hospital

^c Southern Tohoku General Hospital

^d SAPPORO MEDICAL UNIVERSITY   (Japan)

^e HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f Yuri General Hospital

^g Nishiwaki Municipal Hospital

^h KANSAI ROSAI HOSPITAL   (Japan)

ⁱ NATIONAL HOSPITAL ORGANIZATION MITO MEDICAL CENTER   (Japan)

^j Kobe City Public Health Center   (Japan)

^k Toyooka Hospital   (Japan)

^l OKAYAMA ROSAI HOSPITAL   (Japan)

^m SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

ⁿ National Cardiovascular Center

more..

Author keywords

Genetic analysis; Genetic factor; HLA analysis; Moyamoya disease; Pathophysiological investigations

Indexed keywords

ANGIOGENESIS; ARTICLE; ASIAN; CAROTID ARTERY OBSTRUCTION; ETHNICITY; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; LINKAGE ANALYSIS; MOYAMOYA DISEASE; PATHOPHYSIOLOGY;

CHROMOSOME MAPPING; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HLA ANTIGENS; HUMANS; MOYAMOYA DISEASE;

EID: 57349153292     PISSN: 18816096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Suzuki J, Takaku A: Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20: 288-299, 1969
2. Suzuki J, Kodama N: Cerebrovascular "Moyamoya" disease 2. Collateral routes to forebrain via ethmoid sinus and superior nasal meatus. Angiology 22: 223-236, 1971
3. Wakai K, Tamakoshi A, Ikezaki K, Fukui M, et al: Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg 99 (Suppl 2): S1-5, 1997
4. Baba T, Houkin K Kuroda S: Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry, 79: 900-904, 2007
5. Kuriyama S, Kusaka Y, Fujimura M, Wakai K, Tamakoshi A, et al: Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke 39: 42-47, 2008
6. Ikeda K, Iwasaki Y, Kashihara H, Hosozawa K, Anan K, et al: Adult moyamoya disease in the asymptomatic Japanese population. J Clin Neurosci 13: 334-338, 2006
7. Akasaki T, Kagiyama S, Omae T, Ohya Y, Ibayashi S, et al: Asymptomatic moyamoya disease associated with coronary and renal artery stenoses-a case report. Jpn Circ J 62: 136-138, 1998
8. No Shinkei Geka 31: 1291-1295, 2003
9. Goto Y, Yonekawa Y: Worldwide distribution of moyamoya disease. Neurol Med Chir (Tokyo) 32: 883-886, 1992
10. Fukui M, Kono S, Sueishi K, Ikezaki K: Moyamoya disease. Neuropathology 20 (Suppl): S61-64, 2000
11. Nanba R, Tada M, Kuroda S, Houkin K, Iwasaki Y: Sequence analysis and bioinformatics analysis of chromosome 17q25 in familial moyamoya disease. Childs Nerv Syst 21: 62-68, 2005
12. Mineharu Y, Takenaka K, Yamakawa H, Inoue K, Ikeda H, et al: Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting. J Neurol Neurosurg Psychiatry 77: 1025-1029, 2006
13. Fukui M: Current state of study on moyamoya disease in Japan. Surg Neurol 47: 138-143, 1997
14. Fukui M (ed): The Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. 1994, pp133-135
15. Fukui M: Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). The Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 99 (Suppl 2): S238-240, 1997
16. Aoyagi M, Fukai N, Matsushima Y, Yamamoto M, Yamamoto K: Kinetics of 125I-PDGF binding and down-regulation of PDGF receptor in arterial smooth muscle cells derived from patients with moyamoya disease. J Cell Physiol 154: 281-288, 1993
17. Aoyagi M, Fukai N, Sakamoto H, Shinkai T, Matsushima Y, et al: Altered cellular responses to serum mitogens, including platelet-derived growth factor, in cultured smooth muscle cells derived from arteries of patients with moyamoya disease. J Cell Physiol 147: 191-198, 1991
18. Hoshimaru M, Takahashi JA, Kikuchi H, Nagata I, Hatanaka M: Possible roles of basic fibroblast growth factor in the pathogenesis of moyamoya disease: an immunohistochemical study. J Neurosurg 75: 267-270, 1991
19. Takahashi A, Sawamura Y, Houkin K, Kamiyama II, Abe H: The cerebrospinal fluid in patients with moyamoya disease (spontaneous occlusion of the circle of Willis) contains high level of basic fibroblast growth factor. Neurosci Lett 160: 214-216, 1993
20. Aoyagi M, Fukai Y, Yamamoto M, Nakagawa K, Matsushima Y, et al: Early development of intimal thickening in superficial temporal arteries in patients with moyamoya disease. Stroke 27: 1750-1754, 1996
21. Yoshimoto T, Houkin K, Takahashi A, Abe H: Angiogenic factors in moyamoya disease. Stroke 27: 2160-2165, 1996
22. Yamamoto M, Aoyagi M, Tajima S, Wachi H, Fukai N, et al: Increase in elastin gene expression and protein synthesis in arterial smooth muscle cells derived from patients with Moyamoya disease. Stroke 28: 1733-1738, 1997
23. Yoshimoto T, Houkin K, Takahashi A, Abe H: Evaluation of cytokines in cerebrospinal fluid from patients with moyamoya disease. Clin Neurol Neurosurg 99 (Suppl 2): S218-220, 1997
24. Hojo M, Hoshimaru M, Miyamoto S, Taki W, Nagata I, et al: Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease. J Neurosurg 89: 623-629, 1998
25. Houkin K, Yoshimoto T, Abe H, Nagashima K, Takeda M, et al: Role of basic fibroblast growth factor in the pathogenesis of moyamoya disease. Neurosurg Focus 5: e2, 1998
26. Yamamoto M, Aoyagi M, Fukai N, Matsushima Y, Yamamoto K: Increase in prostaglandin E (2) production by interleukin-1beta in arterial smooth muscle cells derived from patients with moyamoya disease. Circ Res 85: 912-918, 1999
27. Kim SK, Yoo JI, Cho BK, Hong SJ, Kim YK, Moon JA, et al: Elevation of CRABP-I in the cerebrospinal fluid of patients with Moyamoya disease. Stroke 34: 2835-2841, 2003
28. Nanba R, Kuroda S, Ishikawa T, Houkin K, Iwasaki Y: Increased expression of hepatocyte growth factor in cerebrospinal fluid and intracranial artery in moyamoya disease. Stroke 35: 2837-2842, 2004
29. Takagi Y, Kikuta Y, Sadamasa N, Nozaki K, Hashimoto N: Caspase-3-dependent apoptosis in middle cerebral arteries in patients with moyamoya disease. Neurosurgery 59: 894-900, discussion 900-901, 2006
30. Takagi Y, Kikuta K, Nozaki K, Fujimoto M, Hayashi J, et al: Expression of hypoxia-inducing factor-1 alpha and endoglin in intimal hyperplasia of the middle cerebral artery of patients with Moyamoya disease. Neurosurgery 60: 338-345, discussion 345, 2007
31. Sakamoto S, Kiura Y, Yamasaki F, Shibukawa M, Ohba S, et al: Expression of vascular endothelial growth factor in dura mater of patients with moyamoya disease. Neurosurg Rev 31: 77-81, discussion 81, 2008
32. Ueno M, Kira R, Matsushima T, Inoue T, Fukui M, et al: Moyamoya disease and transforming growth factor-betal. J Neurosurg 92: 907-908, 2000
33. Yoshihara T, Taguchi A, Matsuyama T, Shimizu Y, Kikuchi-Taura A, et al: Increase in circulating CD34-positive cells in patients with angiographic evidence of moyamoya-like vessels. J Cereb Blood Flow Metab 28: 1086-1089, 2008
34. Czartoski T, Hallam D, Lacy JM, Chun MR, Becker K: Postinfectious vasculopathy with evolution to moyamoya syndrome. J Neurol Neurosurg Psychiatry 76: 256-259, 2005
35. El Ramahi KM, Al Rayes HM: Systemic lupus erythematosus associated with moyamoya syndrome. Lupus 9: 632-636, 2000
36. Takanashi J, Sugita K, Miyazato S, Sakao E, Miyamoto H, et al: Antiphospholipid antibody syndrome in childhood strokes. Pediatr Neurol 13: 323-326, 1995
37. Booth F, Yanofsky R, Ross IB, Lawrence P, Onen K: Primary antiphospholipid syndrome with moyamoyalike vascular changes. Pediatr Neurosurg 31: 45-48, 1999
38. Shuja-Ud-Din MA, Ahamed SA, Baidas G, Naeem M: Moyamoya syndrome with primary antiphospholipid syndrome. Med Princ Pract 15: 238-241, 2006
39. Nakamura K, Yanaka K, Ihara S, Nose T: Multiple intracranial arterial stenoses around the circle of Willis in association with Graves' disease: report of two cases. Neurosurgery 53: 1210-1214, discussion 1214-1215, 2003
40. Sasazuki T, Nishimura Y, Muto M, Ohta N: HLA-linked genes controlling immune response and disease susceptibility. Immunol Rev 70: 51-75, 1983
41. Hugot JP, Laurent-Puig P, Gower-Rousseau C, Caillat-Zucman S, Beaugerie L, et al: Linkage analyses of chromosome 6 loci, including HLA, in familial aggregations of Crohn disease. G. E. T. A. I. D. Am J Med Genet 52: 207-213, 1994
42. Satsangi J, Welsh KI, Bunce M, Julier C, Farrant JM, et al: Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 347: 1212-1217, 1996
43. Kitahara T, Okumura K, Semba A, Yamaura A, Makino H: Genetic and immunologic analysis on moya-moya. J Neurol Neurosurg Psychiatry 45: 1048-1052, 1982
44. Aoyagi M, Ogami K, Matsushima Y, Shikata M, Yamamoto M, et al: Human leukocyte antigen in patients with moyamoya disease. Stroke 26: 415-417, 1995
45. Inoue TK, Ikezaki K, Sasazuki T, Matsushima T, Fukui M: Analysis of class II genes of human leukocyte antigen in patients with moyamoya disease. Clin Neurol Neurosurg 99 (Suppl 2): S234-237, 1997
46. Han H, Pyo CW, Yoo DS, Huh PW, Cho KS, et al: Associations of Moyamoya patients with HLA class I and class II alleles in the Korean population. J Korean Med Sci 18: 876-880, 2003
47. Ikeda H, Sasaki T, Yoshimoto T, Fukui M, Arinami T: Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet 64: 533-537, 1999
48. Inoue TK, Ikezaki K, Sasazuki T, Matsushima T, Fukui M: Linkage analysis of moyamoya disease on chromosome 6. J Child Neurol 15: 179-182, 2000
49. Yamauchi T, Tada M, Houkin K, Tanaka T, Nakamura Y, et al: Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke 31: 930-935, 2000
50. Sakurai K, Horiuchi Y, Ikeda H, Ikezaki K, Yoshimoto T, et al: A novel susceptibility locus for moyamoya disease on chromosome 8q23. J Hum Genet 49: 278-281, 2004
51. Kang HS, Kim SK, Cho BK, Kim YY, Hwang YS, et al: Single nucleotide polymorphisms of tissue inhibitor of metalloproteinase genes in familial moyamoya disease. Neurosurgery 58: 1074-1080, discussion 1074-1080, 2006
52. Mineharu Y, Liu W, Inoue K, Matsuura N, Inoue S, et al: Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology 70: 2357-2363, 2008